HANXBIO-B (03378) spent 1.1521 million Hong Kong dollars to repurchase 43,800 shares on June 10th.
Hansard Group Limited (03378) announced that it will spend 1.1521 million Hong Kong dollars to repurchase 43,800 shares on June 10, 2026.
HANXBIO-B (03378) announced that it spent HK$1,152,100 to repurchase 43,800 shares on June 10, 2026.
Related Articles
NUOBIKAN (02635): Cao Xiaoxue appointed as a member of the nomination committee.
WELLCELL H-NEW (02477) main shareholder, WELLCELL H-NEW Group, plans to sell a total of 576 million shares of the company.
HEARTCARE-B(06609): Ding Kui resigns as non-executive director
NUOBIKAN (02635): Cao Xiaoxue appointed as a member of the nomination committee.
WELLCELL H-NEW (02477) main shareholder, WELLCELL H-NEW Group, plans to sell a total of 576 million shares of the company.
HEARTCARE-B(06609): Ding Kui resigns as non-executive director
RECOMMEND
